Umar, Tungki Pratama, et al. “Urokinase Plasminogen Activator Receptor (uPAR) Targeted Therapy With Switchable Chimeric Antigen Receptor T-Cell (sCAR T-Cell) Potential As Pancreatic Cancer Immunotherapy Agent”. International Journal of Human and Health Sciences (IJHHS), vol. 5, no. 2, Oct. 2020, pp. 171-6, doi:10.31344/ijhhs.v5i2.255.